Основные моменты месяца JoVE: август 2017
4 августа 2017 г.
1.7K просмотров
Overview
This preview highlights key studies featured in the August 2017 issue of JoVE, spanning topics from wildlife biology and developmental neuroscience to tissue engineering and neurotechnology. The issue showcases innovative protocols and imaging techniques that advance understanding in diverse areas of life sciences and bioengineering.
Key Study Components
Area of Science
- Biology
- Bioengineering
- Neuroscience
Background
- Understanding the interplay between genetics and environment in animal development is crucial for wildlife management.
- Real-time imaging of embryonic development provides insights into cellular migration and tissue formation.
- Engineering vascularized tissues is a major challenge in regenerative medicine.
- Assessing consciousness in non-communicative patients is a significant clinical need.
Purpose of Study
- To determine the relative effects of environment and genetics on white-tailed deer development.
- To visualize and track neural crest cell migration in developing zebrafish embryos.
- To develop a microfluidic bioprinting method for engineering vascularized tissues and organoids.
- To establish brain-computer interface paradigms for assessing and enabling communication in patients with disorders of consciousness.
Methods Used
- Relocation of deer to controlled habitats and measurement of phenotypic traits over generations.
- Multi-photon time-lapse imaging of live zebrafish embryos.
- Microfluidic bioprinting to create microfibrous scaffolds for tissue engineering.
- Electroencephalography (EEG)-based brain-computer interface tasks for patient assessment.
Main Results
- Deer phenotypic variation was more strongly influenced by nutrition than by genetics.
- Live imaging enabled real-time tracking of neural crest cell migration and eye development in zebrafish.
- Engineered scaffolds supported the formation of lumen-like, vascular structures by epithelial cells.
- Patients with disorders of consciousness could complete EEG-based tasks, indicating potential for communication.
Conclusions
- Nutritional factors can outweigh genetic background in determining certain developmental traits in wildlife.
- Advanced imaging techniques facilitate the study of developmental processes and congenital anomalies.
- Microfluidic bioprinting offers promising avenues for creating vascularized tissues in vitro.
- Hybrid brain-computer interfaces may provide new communication pathways for non-responsive patients.
Frequently Asked Questions
What was the main finding regarding white-tailed deer development?
The study found that nutritional factors had a greater impact on body mass and antler size than population-level genetics.
How were neural crest cells studied in zebrafish?
Researchers used multi-photon time-lapse imaging to track the migration of neural crest cells in live zebrafish embryos.
What innovation was introduced in tissue engineering?
A novel microfluidic bioprinting technique was used to create microfibrous scaffolds that support the formation of vascularized tissues and organoids.
How did the neuroscience study assess consciousness in patients?
The study used EEG-based brain-computer interface paradigms to monitor brain activity and assess responses to specific tasks in patients unable to provide motor responses.
Can the imaging techniques used in zebrafish be applied to other tissues?
Yes, the multi-photon time-lapse imaging approach can be adapted to visualize the development of various tissues in real time.
What is the significance of the brain-computer interface findings?
The results suggest that even patients with severe disorders of consciousness may be able to communicate through brain activity, offering hope for improved patient care.
Executive Industry Relevance
The August 2017 JoVE highlights showcase advances in developmental biology, tissue engineering, and neurotechnology with direct implications for biopharma R&D. These studies demonstrate how controlled experimental systems, quantitative imaging, and engineered tissue models can de-risk early discovery and enable translational insights. The integration of such methods supports predictive confidence and informs portfolio decisions across discovery and preclinical pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Controlled habitat studies clarify the relative impact of genetics versus environment on phenotypic traits.
- Quantitative measurement of developmental outcomes supports mechanistic de-risking in model systems.
- Real-time imaging of cell migration enables functional target validation in developmental pathways.
Screening & Assay Development
- Microfluidic bioprinting produces reproducible, vascularized tissue scaffolds for compound screening.
- Standardized imaging protocols facilitate assay reproducibility and quantitative phenotypic readouts.
- Engineered organoids and tissues expand the range of disease-relevant screening platforms.
Translational & Preclinical Research
- Live imaging in zebrafish models supports alignment with mammalian developmental processes.
- Engineered vascularized tissues bridge discovery and preclinical validation for regenerative medicine.
- Brain-computer interface paradigms offer translational potential for neurological disorder assessment.
Pipeline & Workflow Integration
These methods position discovery teams to advance from hypothesis testing through assay development and translational research with greater predictive value.
- Discovery Biology: Quantitative trait analysis and live imaging clarify biological mechanisms and reduce ambiguity.
- Screening: Engineered tissues and standardized imaging enable robust, scalable assay platforms.
- Analytics: Quantitative outputs from imaging and phenotypic measurements support cross-condition comparisons.
- Translational Research: Disease-relevant models and neurotechnology approaches facilitate preclinical continuity.
- Enterprise Reuse: Protocols for bioprinting and imaging are adaptable across multiple R&D programs.
Operational & Enterprise Impact
- Scientific Value: Enhanced predictive confidence and mechanistic clarity in early-stage research.
- Operational Value: Standardized, reproducible workflows for tissue engineering and imaging.
- Strategic Value: Improved go/no-go decisions and reduced risk in advancing candidates.
- Portfolio Impact: Broader applicability of validated models and assays across therapeutic areas.
Implementation Considerations
- Expertise in quantitative imaging and tissue engineering is required for protocol execution.
- Access to multi-photon microscopy and microfluidic bioprinting infrastructure is necessary.
- Cross-team standardization ensures reproducibility and data comparability.
- Adaptation of protocols may be needed for different species or tissue types.
- Limitations include model-specific constraints and the need for specialized analytical tools.
Biopharma FAQs
Why does null hypothesis testing matter for deer trait analysis?
Null hypothesis testing in controlled deer studies enables teams to distinguish the effects of environment versus genetics, supporting robust target validation and reducing mechanistic uncertainty in trait development.
How does independent variable isolation fit zebrafish imaging workflows?
Isolating environmental and genetic variables in zebrafish imaging allows precise attribution of observed developmental changes, strengthening the predictive value of phenotypic screening in early discovery.
What do quantitative dependent variable measurements enable in tissue engineering?
Quantitative measurements of lumen formation and vascularization in engineered tissues provide objective criteria for assay readiness and facilitate reliable comparison across experimental conditions.
Why are replication requirements critical for brain-computer interface studies?
Replication ensures that EEG-based communication findings in patients with disorders of consciousness are robust, enabling cross-functional teams to trust and build upon these neurotechnology outputs.
What statistical analysis capabilities are required before implementing microfluidic bioprinting assays?
Robust statistical analysis is needed to validate reproducibility and significance of engineered tissue outcomes, ensuring that bioprinting assays meet enterprise standards for screening and translational research.